J. Montaner

Latest

• Determination of Clinically Relevant Cutoffs for HIV-1 Phenotypic Resistance Estimates Through a Combined Analysis of Clinical Trial and Cohort Data
• The effect of baseline CD4 cell count and HIV-1 viral load on the efficacy and safety of nevirapine or efavirenz-based first-line HAART
• A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients